Back to Search Start Over

ROBUST: First report of phase III randomized study of lenalidomide/R‐CHOP (R2‐CHOP) vs placebo/R‐CHOP in previously untreated ABC‐type diffuse large B‐cell lymphoma.

Authors :
Vitolo, U.
Witzig, T.E.
Gascoyne, R.D.
Scott, D.W.
Zhang, Q.
Jurczak, W.
Özcan, M.
Hong, X.
Zhu, J.
Jin, J.
Belada, D.
Bergua, J.M.
Piazza, F.
Mócikova, H.
Molinari, A.L.
Yoon, D.H.
Cavallo, F.
Tani, M.
Izutsu, K.
Kato, K.
Source :
Hematological Oncology; Jun2019 Supplement S2, Vol. 37, p36-37, 2p
Publication Year :
2019

Subjects

Subjects :
DIFFUSE large B-cell lymphomas
CORE needle biopsy

Details

Language :
English
ISSN :
02780232
Volume :
37
Database :
Complementary Index
Journal :
Hematological Oncology
Publication Type :
Academic Journal
Accession number :
137029396
Full Text :
https://doi.org/10.1002/hon.5_2629
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details